Home Stock

Stock Research: BioLife Slutn

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

BioLife Slutn

NAQ:BLFS US09062W2044
74
  • Value
    6
  • Growth
    99
  • Safety
    Safety
    29
  • Combined
    34
  • Sentiment
    96
  • 360° View
    360° View
    74
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

BioLife Solutions, Inc. develops and supplies cell processing tools and services for the cell and gene therapy (CGT) market. The company operates in the cell and gene therapy market, offering solutions for cell preservation and processing. Its products include CryoStor freeze media, Sexton cell processing product line, CellSeal cryogenic vials, and ThawSTAR thawing devices. In the last fiscal year, the company had a market cap of $1,000 million, profits of $54 million, and revenue of $82 million with 159 employees.

more
Strongest Rank Price vs. Earnings (P/E)
Weakest Rank Growth
Country USA
Industry Life Sciences Tools & Services
Size Small
Website biolifesolutions.com
Index
NASDAQ
BioLife Slutn stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 27-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
6 20 44 63
Growth
99 91 27 71
Safety
Safety
29 20 56 56
Sentiment
96 82 33 17
360° View
360° View
74 71 81 57
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
85 84 61 23
Opinions Change
50 50 50 50
Pro Holdings
n/a 63 32 75
Market Pulse
54 40 36 16
Sentiment
96 82 33 17
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
6 20 44 63
Growth
99 91 27 71
Safety Safety
29 20 56 56
Combined
34 33 72 72
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
7 11 38 62
Price vs. Earnings (P/E)
1 58 58 6
Price vs. Book (P/B)
46 40 58 79
Dividend Yield
1 1 1 1
Value
6 20 44 63
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
88 4 10 71
Profit Growth
96 90 90 9
Capital Growth
78 95 9 91
Stock Returns
61 87 47 53
Growth
99 91 27 71
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
95 60 53 62
Refinancing
37 18 39 31
Liquidity
6 14 28 28
Safety Safety
29 20 56 56

Similar Stocks

Discover high‑ranked alternatives to BioLife Slutn and broaden your portfolio horizons.

Global Payments

NYQ:GPN
Country: USA
Industry: Other Financial Services
Size: X-Large
Full Stock Analysis

Omnicom

NYQ:OMC
Country: USA
Industry: Advertising
Size: X-Large
Full Stock Analysis

Mosaic

NYQ:MOS
Country: USA
Industry: Fertilizers & Agricultural Chemicals
Size: X-Large
Full Stock Analysis

Labcorp

NYQ:LH
Country: USA
Industry: Health Care Services
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

The value case is weak (expensive and low Growth Rank), but sentiment is strong and financing is safe. This scenario may indicate future growth not yet in current financials. This is a speculative choice for investors with a high-risk appetite who are betting on the positive sentiment and safe financing to sustain a long-term turnaround.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews